1. Ramelteon protects against social defeat stress-associated abnormal behaviors.
- Author
-
Chen CW, Yeh WL, Charoensaensuk V, Lin C, Yang LY, Xie SY, Lane HY, Lin CH, Wang YW, Tsai CF, and Lu DY
- Subjects
- Animals, Mice, Male, Behavior, Animal drug effects, Hippocampus drug effects, Hippocampus metabolism, Receptors, Glucocorticoid metabolism, Receptors, Glucocorticoid agonists, Receptor, Melatonin, MT1 agonists, Receptor, Melatonin, MT1 metabolism, Receptor, Melatonin, MT2 agonists, Receptor, Melatonin, MT2 metabolism, Mice, Inbred C57BL, Monoamine Oxidase metabolism, Receptors, Melatonin agonists, Receptors, Melatonin metabolism, Stress Disorders, Post-Traumatic drug therapy, Stress Disorders, Post-Traumatic psychology, Stress Disorders, Post-Traumatic metabolism, Indenes pharmacology, Stress, Psychological metabolism, Stress, Psychological drug therapy, Social Defeat, Melatonin pharmacology, Anxiety drug therapy, Anxiety psychology
- Abstract
Psychological stress affects the neuroendocrine regulation, which modulates mental status and behaviors. Melatonin, a hormone synthesized primarily by the pineal gland, regulates many brain functions, including circadian rhythms, pain, sleep, and mood. Selective pharmacological melatonin agonist ramelteon has been clinically used to treat mood and sleep disorders. Posttraumatic stress disorder (PTSD) is a psychiatric condition associated with severe trauma; it is generally triggered by traumatic events, which lead to severe anxiety and uncontrollable trauma recall. We recently reported that repeated social defeat stress (RSDS) may induce robust anxiety-like behaviors and social avoidance in mice. In the present study, we investigated whether melatonin receptor activation by melatonin and ramelteon regulates RSDS-induced behavioral changes. Melatonin treatment improved social avoidance and anxiety-like behaviors in RSDS mice. Moreover, treatment of the non-selective MT
1 /MT2 receptor agonist, ramelteon, markedly ameliorated RSDS-induced social avoidance and anxiety-like behaviors. Moreover, activating melatonin receptors also balanced the expression of monoamine oxidases, glucocorticoid receptors, and endogenous antioxidants in the hippocampus. Taken together, our findings indicate that the activation of both melatonin and ramelteon regulates RSDS-induced anxiety-like behaviors and PTSD symptoms. The current study also showed that the regulatory effects of neuroendocrine mechanisms and cognitive behaviors on melatonin receptor activation in repeated social defeat stress., Competing Interests: Declaration of competing interest The authors declare that they have no conflict of interest., (Copyright © 2024. Published by Elsevier Inc.)- Published
- 2024
- Full Text
- View/download PDF